Tacrolimus and Abdominal wound dehiscence - a phase IV clinical study of FDA data

Summary:

Abdominal wound dehiscence is reported as a side effect among people who take Tacrolimus (tacrolimus), especially for people who are female, 60+ old, also take Nystatin, and have Hepatoblastoma.

The phase IV clinical study analyzes which people have Abdominal wound dehiscence when taking Tacrolimus. It is created by eHealthMe based on reports of 115,828 people who have side effects when taking Tacrolimus from the FDA, and is updated regularly.

What is Tacrolimus?

Tacrolimus has active ingredients of tacrolimus. It is often used in kidney transplant. eHealthMe is studying from 116,161 Tacrolimus users. Check the latest studies of Tacrolimus.

What is Abdominal wound dehiscence?

Abdominal wound dehiscence (abdominal wound ruptures) is found to be associated with 88 drugs and 188 conditions by eHealthMe. Check the latest studies of Abdominal wound dehiscence.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

115,828 people reported to have side effects when taking Tacrolimus.
Among them, 12 people (0.01%) have Abdominal wound dehiscence.

Could Tacrolimus cause Abdominal wound dehiscence?

Among these 12 people:

What is the gender of people who have Abdominal wound dehiscence when taking Tacrolimus? *

female: 75 %
male: 25 %

What is the age of people who have Abdominal wound dehiscence when taking Tacrolimus? *

What are other drugs people take besides Tacrolimus? *

Lansoprazole: 3 people, 25.00%
Doxorubicin Hydrochloride: 3 people, 25.00%
Magnesium: 3 people, 25.00%
Ursodiol: 3 people, 25.00%
Amiloride Hydrochloride: 3 people, 25.00%
Aspirin: 3 people, 25.00%
Prednisone: 3 people, 25.00%
Carboplatin: 3 people, 25.00%
Nystatin: 3 people, 25.00%
Mycophenolate Mofetil: 2 people, 16.67%

What are other side effects people have besides Abdominal wound dehiscence? *

Aplastic Anemia: 3 people, 25.00%
Urinary Tract Infection: 3 people, 25.00%
Colitis (inflammation of colon): 3 people, 25.00%
Febrile Neutropenia (fever with reduced white blood cells): 3 people, 25.00%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 3 people, 25.00%
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 3 people, 25.00%
Infection: 2 people, 16.67%
Asphyxia (a condition in which there is an extreme decrease in the concentration of oxygen in the body): 2 people, 16.67%
Depression: 2 people, 16.67%
Dyspnea (difficult or laboured breathing): 2 people, 16.67%

What are the existing conditions these people have? *

Hepatoblastoma (liver cancer): 3 people, 25.00%
Thyroid Diseases: 2 people, 16.67%
Renal Disorder (kidney disease): 2 people, 16.67%
Renal Osteodystrophy (a bone disease occurs when the kidneys fail to maintain the proper levels of calcium and phosphorus in the blood): 1 person, 8.33%
Metabolic Acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body): 1 person, 8.33%
Kidney Transplant Rejection: 1 person, 8.33%
Immunodeficiency Disorders: 1 person, 8.33%
Hypophosphataemia (electrolyte disturbance in which there is an abnormally low level of phosphate in the blood): 1 person, 8.33%
Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 8.33%
High Blood Pressure: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Tacrolimus and have Abdominal wound dehiscence?

- Check whether Abdominal wound dehiscence is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tacrolimus:

Tacrolimus (116,161 reports)

Browse all side effects of Tacrolimus:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Abdominal wound dehiscence:

Abdominal wound dehiscence (88 drugs)

Browse all the conditions that are associated with Abdominal wound dehiscence:

Abdominal wound dehiscence (188 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on tacrolimus (the active ingredients of Tacrolimus) and Tacrolimus (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.